10058-F4 compound,
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one,
10058-F4,
403811-55-2,
(5E)-5-(4-ethylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one,
5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone,
c-Myc Inhibitor,
(E)-5-(4-Ethylbenzylidene)-2-mercaptothiazol-4(5H)-one,
(Z,E)-5-(4-Ethylbenzylidine)-2-thioxothiazolidin-4-one,
AC1LOUPZ,
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one,
CHEMBL1568415,
SCHEMBL10042186,
EX-A660,
HMS3260I13,
ALBB-009118,
BCP08097,
ZX-AN008013,
ZX-CM001457,
Tox21_500046,
MFCD00758517,
MFCD04969046,
s7153,
ZINC12406714,
AKOS000307369,
AKOS003017633,
CCG-221350,
CS-3965,
LP00046,
RTR-016130,
SB19479,
NCGC00185994-01,
NCGC00260731-01,
AJ-38681,
HY-12702,
SC-94645,
TR-016130,
BB 0259511,
SW219661-1,
10058-F4, >=98% (HPLC), solid,
A13725,
Y-1489,
AB00084200-01,
SR-01000208026,
SR-01000208026-1,
(5E)-5-[(4-ethylphenyl)methylidene]-2-sulfanyl-1,3-thiazol-4-one,
(5E)-5-[(4-ethylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one,
5-[(4-ethylphenyl)methylidene]-2-sulfanyl-4,5-dihydro-1,3-thiazol-4-one,
10058-F4 compound,
SVXDHPADAXBMFB-JXMROGBWSA-N,
ZINC01085341,
ACN-025781,
CID1271002,
-5- -2-THIOXOTHIAZOLIDIN-4-ONE,
C524814,
4-Thiazolidinone, 5-[(4-ethylphenyl)methylene]-2-thioxo-,